Proteins

Extinction CoeffA280 nm = 1.0 at 1.0 mg/mLSpecificityMonospecific for C3a in human plasmaGeneral DescriptionProduct is whole polyclonal antiserum from rabbits immunized with highly purified human complement protein. The product is not a purified IgG

Extinction CoeffA280 nm = 1.0 at 1.0 mg/mLSpecificityMonospecific for C4a in human plasmaGeneral DescriptionProduct is whole polyclonal antiserum from rabbits immunized with highly purified human complement protein. Product is not a purified IgG

Product description：Extinction Coeff：A280 nm = 1.0 at 1.0 mg/mLSpecificity: Monospecific for C5a and C5adesArg in human plasmaGeneral DescriptionProduct is whole polyclonal antiserum from rabbits immunized with highly purified human complement

Extinction Coeff.A280 nm = 1.35 at 1.0 mg/mLSpecificityMonospecific for human SC5b-9 complex in plasma. No reaction occurs with non-activated normal human serum or plasma. Reacts with cell surface bound C5b-9 complexGeneral DescriptionProduct is

Extinction Coeff. A280 nm = 1.0 at 1.0 mg/mLSpecificityMonospecific for vitronectin in human plasmaGeneral DescriptionProduct is whole polyclonal antiserum from rabbits immunized with highly purified human complement protein. Product is not a

Rabbit IgG Antibody: Isotype Control Antibody.

Rabbit IgG Antibody: Isotype Control Antibody.

rac-CCT-250863 HCl is a selective and reversible inhibitor of NEK 2. rac-CCT-250863 HCl induces cell cycle arrest and has good anti-proliferative activity against cancer cells. rac-CCT-250863 HCl can be used in combination with Pomalidomide to

rac-CCT-250863 HCl is a selective and reversible inhibitor of NEK 2. rac-CCT-250863 HCl induces cell cycle arrest and has good anti-proliferative activity against cancer cells. rac-CCT-250863 HCl can be used in combination with Pomalidomide to

rac-CCT-250863 HCl is a selective and reversible inhibitor of NEK 2. rac-CCT-250863 HCl induces cell cycle arrest and has good anti-proliferative activity against cancer cells. rac-CCT-250863 HCl can be used in combination with Pomalidomide to

rac-CCT-250863 HCl is a selective and reversible inhibitor of NEK 2. rac-CCT-250863 HCl induces cell cycle arrest and has good anti-proliferative activity against cancer cells. rac-CCT-250863 HCl can be used in combination with Pomalidomide to

rac-CCT-250863 HCl is a selective and reversible inhibitor of NEK 2. rac-CCT-250863 HCl induces cell cycle arrest and has good anti-proliferative activity against cancer cells. rac-CCT-250863 HCl can be used in combination with Pomalidomide to